164 related articles for article (PubMed ID: 24500394)
1. Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice.
Goto T; Hagiwara K; Shirai N; Yoshida K; Hagiwara H
Cytotechnology; 2015 Mar; 67(2):357-65. PubMed ID: 24500394
[TBL] [Abstract][Full Text] [Related]
2. Olive polyphenol hydroxytyrosol prevents bone loss.
Hagiwara K; Goto T; Araki M; Miyazaki H; Hagiwara H
Eur J Pharmacol; 2011 Jul; 662(1-3):78-84. PubMed ID: 21539839
[TBL] [Abstract][Full Text] [Related]
3. 4-Hydroxyderricin inhibits osteoclast formation and accelerates osteoblast differentiation.
Hagiwara H; Nakata K; Miyazaki H; Maehashi S; Komiyama Y; Aida R; Yoshida S; Kokubu D; Hagiwara K; Yoshida K
Cytotechnology; 2019 Feb; 71(1):15-22. PubMed ID: 30474804
[TBL] [Abstract][Full Text] [Related]
4. 8,8''-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8''-biapigeninyl in ovariectomized mice.
Siddiqui JA; Swarnkar G; Sharan K; Chakravarti B; Sharma G; Rawat P; Kumar M; Khan FM; Pierroz D; Maurya R; Chattopadhyay N
Mol Cell Endocrinol; 2010 Jul; 323(2):256-67. PubMed ID: 20380869
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of osteoclastogenesis and osteoclast function by apigenin.
Bandyopadhyay S; Lion JM; Mentaverri R; Ricupero DA; Kamel S; Romero JR; Chattopadhyay N
Biochem Pharmacol; 2006 Jul; 72(2):184-97. PubMed ID: 16750176
[TBL] [Abstract][Full Text] [Related]
6. Anti-osteoporotic activity of harpagide by regulation of bone formation in osteoblast cell culture and ovariectomy-induced bone loss mouse models.
Chung HJ; Kyung Kim W; Joo Park H; Cho L; Kim MR; Kim MJ; Shin JS; Ho Lee J; Ha IH; Kook Lee S
J Ethnopharmacol; 2016 Feb; 179():66-75. PubMed ID: 26712566
[TBL] [Abstract][Full Text] [Related]
7. Apigenin increases osteoblastic differentiation and inhibits tumor necrosis factor-alpha-induced production of interleukin-6 and nitric oxide in osteoblastic MC3T3-E1 cells.
Choi EM
Pharmazie; 2007 Mar; 62(3):216-20. PubMed ID: 17416199
[TBL] [Abstract][Full Text] [Related]
8. Anti-Osteoporotic Activity of Harpagoside by Upregulation of the BMP2 and Wnt Signaling Pathways in Osteoblasts and Suppression of Differentiation in Osteoclasts.
Chung HJ; Kim WK; Oh J; Kim MR; Shin JS; Lee J; Ha IH; Lee SK
J Nat Prod; 2017 Feb; 80(2):434-442. PubMed ID: 28106392
[TBL] [Abstract][Full Text] [Related]
9. Pomegranate seed oil prevents bone loss in a mice model of osteoporosis, through osteoblastic stimulation, osteoclastic inhibition and decreased inflammatory status.
Spilmont M; Léotoing L; Davicco MJ; Lebecque P; Mercier S; Miot-Noirault E; Pilet P; Rios L; Wittrant Y; Coxam V
J Nutr Biochem; 2013 Nov; 24(11):1840-8. PubMed ID: 23953990
[TBL] [Abstract][Full Text] [Related]
10. Anti-Osteoporotic Effects of Kukoamine B Isolated from
Park E; Kim J; Kim MC; Yeo S; Kim J; Park S; Jo M; Choi CW; Jin HS; Lee SW; Li WY; Lee JW; Park JH; Huh D; Jeong SY
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174394
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Orai1 alters expression of multiple genes during osteoclast and osteoblast maturation.
Hwang SY; Foley J; Numaga-Tomita T; Petranka JG; Bird GS; Putney JW
Cell Calcium; 2012 Dec; 52(6):488-500. PubMed ID: 23122304
[TBL] [Abstract][Full Text] [Related]
12. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
Liu FL; Chen CL; Lai CC; Lee CC; Chang DM
Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293
[TBL] [Abstract][Full Text] [Related]
13. A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption.
Yang YT; Meng JH; Hu B; Ma CY; Zhao CC; Teng WS; Hong JQ; Li SH; Jiang GY; Wang C; Zhou CH; Yan SG
Life Sci; 2018 Sep; 209():409-419. PubMed ID: 30096387
[TBL] [Abstract][Full Text] [Related]
14. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
[TBL] [Abstract][Full Text] [Related]
15. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH
J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
[TBL] [Abstract][Full Text] [Related]
16. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro.
Yuan SY; Sheng T; Liu LQ; Zhang YL; Liu XM; Ma T; Zheng H; Yan Y; Ishimi Y; Wang XX
Chin J Nat Med; 2016 Apr; 14(4):265-269. PubMed ID: 27114313
[TBL] [Abstract][Full Text] [Related]
17. Short-Term Hypoxia Accelerates Bone Loss in Ovariectomized Rats by Suppressing Osteoblastogenesis but Enhancing Osteoclastogenesis.
Wang G; Wang J; Sun D; Xin J; Wang L; Huang D; Wu W; Xian CJ
Med Sci Monit; 2016 Aug; 22():2962-71. PubMed ID: 27550548
[TBL] [Abstract][Full Text] [Related]
18. Antiosteoporotic Effects of
Kuriya K; Nishio M; Wada S; Katsuzaki H; Nishise M; Okamoto H; Umekawa H
J Med Food; 2019 Apr; 22(4):365-373. PubMed ID: 30785809
[TBL] [Abstract][Full Text] [Related]
19. Conjugated linoleic Acid prevents ovariectomy-induced bone loss in mice by modulating both osteoclastogenesis and osteoblastogenesis.
Rahman MM; Fernandes G; Williams P
Lipids; 2014 Mar; 49(3):211-24. PubMed ID: 24338525
[TBL] [Abstract][Full Text] [Related]
20. Effect of prolyl hydroxylase inhibitor-loaded collagen barrier membranes on osteoclastogenesis and osteoblastogenesis.
Edelmayer M; Al-Habbal D; Pensch M; Janjić K; Agis H
J Biomater Appl; 2017 May; 31(10):1370-1379. PubMed ID: 28376673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
